Skip to main content

Peer Review reports

From: PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

Original Submission
22 Oct 2020 Submitted Original manuscript
6 Dec 2020 Reviewed Reviewer Report
10 Dec 2020 Reviewed Reviewer Report
13 Dec 2020 Reviewed Reviewer Report
21 Dec 2020 Reviewed Reviewer Report
21 Dec 2020 Reviewed Reviewer Report
12 Jan 2021 Author responded Author comments - Honglei Feng
Resubmission - Version 2
12 Jan 2021 Submitted Manuscript version 2
14 Jan 2021 Reviewed Reviewer Report
16 Jan 2021 Reviewed Reviewer Report
5 Feb 2021 Reviewed Reviewer Report
10 Feb 2021 Author responded Author comments - Honglei Feng
Resubmission - Version 3
10 Feb 2021 Submitted Manuscript version 3
30 Mar 2021 Author responded Author comments - Honglei Feng
Resubmission - Version 4
30 Mar 2021 Submitted Manuscript version 4
Publishing
2 Apr 2021 Editorially accepted
13 Apr 2021 Article published 10.1186/s12885-021-08138-3

You can find further information about peer review here.

Back to article page